|
|
|
Drug Information

Vegas Lawyer For Help With Nevada Personal Injury Law.
| Erbitux® | |
| Brand Name: | Erbitux® |
| Active Ingredient: | Cetuximab |
| Strength(s): | 100mg/50 mL vial |
| Dosage Form(s): | Injection |
| Company Name: | ImClone Systems Inc.; Bristol-Myers Squibb Co. |
| Availability: | Prescription only |
| *Date Approved by FDA: | February 12, 2004 |
| *Approval by FDA does not mean that the drug is available for consumers at this time. | |
|
What is Erbitux
used for? ·
Erbitux is a chemotherapy medicine (medicine used to kill
cancer cells) that is given in a vein (I.V. infusion). It is used to treat
a type of cancer of the colon or rectum that has spread to other areas of
the body (EGRF-expressing metastatic colorectal carcinoma).
Erbitux is used: ·
with another chemotherapy medicine called irinotecan in
people whose EGFR-expressing metastatic colorectal cancer is not or no
longer shrinking with irinotecan alone ·
alone in people with EGFR-expressing metastatic colorectal
cancer who cannot take irinotecan Special
Warnings with Erbitux:
·
Erbitux
may cause severe reactions during I.V. infusion that may result in death.
The reactions include symptoms that happen suddenly such as trouble
breathing, an itchy swelling on the skin (hives), and low blood pressure.
These severe reactions can happen with any Erbitux infusion, but
have happened more often the first time Erbitux is given.
People that have severe infusion reactions with Erbitux must have
their infusion stopped right away, and cannot be treated with Erbitux
again. ·
Erbitux
may cause a serious lung condition called interstitial lung disease that
results in inflammation, scarring, and hardening of the lungs. ·
Erbitux
often causes skin reactions such as an acne-like rash, drying, cracking,
inflammation, and infections. These
reactions may be worsened by sun exposure. General
Precautions with Erbitux: ·
Wear
sunscreen, hats, and protective clothing, and limit sun exposure during
treatment with Erbitux. ·
Women
who can become pregnant should avoid pregnancy and use contraception
during treatment with Erbitux. Women should not breastfeed during treatment with
Erbitux and for 60 days after the last dose. What should I
tell my health care provider? Tell your health care provider if you are allergic to
any of the ingredients of Erbitux. What are some
possible side effects of Erbitux? (This list is
NOT a complete list of side effects reported with Erbitux.
Your health care provider can discuss with you a more complete list
of side effects.) Serious side effects of Erbitux include: ·
infusion
reaction ·
skin
reactions ·
lung
disease ·
fever ·
infection
in the blood ·
kidney
failure ·
blood
clot in the lung ·
loss
of water and salt from the body (dehydration) ·
diarrhea ·
acne-like
rash ·
tiredness ·
diarrhea ·
nausea ·
abdominal
pain ·
vomiting ·
fever ·
constipation Reports of
patients’ experience after Erbitux became available: For more
detailed information about Erbitux, ask your health care provider or
pharmacist.
Posted 5/26/04 |
Index Of Articles | Las Vegas Attorney | Back To Top
**This information came from an FDA consumer information site**
**This information is not updated - Check for updates at the FDA site**
|
Neither the State Bar of Nevada nor any agency of the State Bar has certified any lawyer identified here as a specialist or as an expert. Anyone considering a lawyer should independently investigate the lawyer's credentials and ability. This site is intended for Nevada residents and those with
legal issues arising under the jurisdiction of the State of Nevada. This site does not give legal advice or create an attorney-client relationship. Laws are different in other states and localities, consult a local attorney. The information in this web site is provided for informational purposes only. The information does not constitute legal advice. The use of this site does not create an attorney-client relationship. Further communication with an attorney through the web site and e-mail may not be considered as confidential or privileged. Please contact our attorneys if you wish to discuss the contents of this web site. If you experience unusual problems with this site or discover dead links, please email the webmaster. Copyright: David Matheny, 2003-2005. |